Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in Persons With HIV
Stopped The study was stopped early due to feasibility concerns.
Conditions
- HIV Infection
- Tuberculosis
Interventions
- DRUG: Standard-dose Lopinavir/Ritonavir
- DRUG: Double-dose Lopinavir/Ritonavir
- DRUG: Raltegravir
- DRUG: Isoniazid
- DRUG: Pyridoxine
- DRUG: Pyrazinamide
- DRUG: Ethambutol
- DRUG: Rifabutin
- DRUG: Rifampin
Sponsor
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Collaborators